Skip to content
Zen Field Insight

Zimbabwe Declines ‘One-Sided’ American Health Aid Agreement Because of Data Concerns

Medical funding image
The offered US funding would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years because of Washington's insistence on confidential data.

The decision was revealed after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".

An official spokesperson has since stated that the US was seeking health data for scientific study and profit but was not willing to share the resulting advantages from any future medical innovations.

"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged further talks to secure a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.

Broader Background

This development comes after a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US following concerns were filed about the safety of Kenyans' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.

According to statements, Sixteen nations in Africa have to date agreed to similar agreements, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to provide its biological resources and data indefinitely, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," Mangwana explained.

"Effectively, our nation would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our citizens if a future pandemic arise."

National Interest and International Frameworks

Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were upending frameworks already established through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This framework is intended to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage further dialogue with our US partners on how subsequent collaboration might be designed in a way that honours the sovereignty and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but suggested that talks should continue considering much of the country's Aids initiatives depended on external financing.

"In cases where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it said.

The situation highlights the continuing challenges between receiving vital foreign assistance and protecting a country's data in an increasingly data-driven world.

The writer

Emily Shelton

Elara Voss is a mindfulness coach and writer with a passion for helping others find balance through Zen practices.

Zen Field Insight

Type to search articles.